First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-05-23
DOI
https://doi.org/10.3389/fimmu.2025.1589042
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect

Patricia Lorenzo-Luaces, Braulio Mestre Fernández, Iraida Caballero Aguirrechu, A. Reyes et al.
Frontiers in Immunology
CAR-T cell therapy research
article

First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect

Patricia Lorenzo-Luaces, Braulio Mestre Fernández, Iraida Caballero Aguirrechu, A. Reyes, Sum Lai Lozada Chang, N. Alonso, Ana Fernández García, Kalet León, Ivis Mendoza Hernández, Daines Mariño de la Puente, M. A. Cardona, Tania Carmenate Portilla, Vilma Fleites Calvo, Gisela García‐Pérez, Jorge Luis García, Tania Crombet Ramos, G. Carvajal, C. Borges, J. Pérez, Elena García López, Nuris Ledón Naranjo, Yanelda García Vega, Alexis Alvárez Lobaina
article en

Abstract

No abstract available for this paper.
Frontiers in ImmunologyVol. 16
Center of Molecular Immunology (Cuba) (CU), Hermanos Ameijeiras Hospital (CU), Cuban Neuroscience Center (CU), Instituto de Oncología y Radiobiología (CU)
Good health and well-being
Openalex Percentile: Top 83%
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

First-in-human evaluation of a no-alpha interleukin–2 mutein: safety and preliminary pharmacodynamic and clinical effect — Patricia Lorenzo-Luaces, Braulio Mestre Fernández, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS